your badges 52W Range $3–$5 4% of range Analyst Rating STRONG BUY 11 analysts Price Target $12 +310% upside P/E 2.2 ROE -113.1% Net Profit Margin -1029.4%

XFOR Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $2.83
Market Cap (MRQ) $272M
P/E (TTM) 2.2
EPS (TTM) $1.27
Revenue (TTM) $9M
ROE (TTM) -113.1%
52W Range $3–$5

XFOR Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

Stock splits 2
Ex-date Split Type
April 28, 2025 1-for-30 Reverse
March 14, 2019 1-for-6 Reverse

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$6M
2018-12-31 → 2025-12-31
EPS$-1.87
2020-12-31 → 2025-12-31
Free Cash Flow$-86M
2018-12-31 → 2025-12-31
Net margin-1029.4%
2018-12-31 → 2025-12-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend XFOR 5Y avg Peer Median Verdict
P/E (TTM) 2.25Y avg ≈-8.9 ≈-8.9 · ·
P/S (TTM) 31.1 · 25.4 Overvalued
P/B (MRQ) 1.75Y avg ≈66.7 ≈66.7 2.9 Fair value
Price / FCF -3.05Y avg ≈-30.1 ≈-30.1 · ·
Price / Cash Flow -3.05Y avg ≈-30.2 ≈-30.2 · ·
Price / Tangible Book (MRQ) 1.95Y avg ≈58.0 ≈58.0 · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise 32.2%
Next Report Nov 03, 2026
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 Aug 6, 2026 $-0.13 $-0.18 29.2%
March 31, 2026 $-0.16 $-0.20 21.6%
Dec. 31, 2025 $-0.22 $-0.35 37.9%
Sept. 30, 2025 $-0.69 $-0.93 26.1%
June 30, 2025 $-3.47 $-4.42 21.6%
March 31, 2025 $0.04 $-4.53 100.9%
Dec. 31, 2024 $-6.00 $-5.36 -12.0%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 17
Metric Trend 20252024202320222021202020192018
Revenue $6M$3M$0$0$0$3M$0$0
Cost of Revenue $6M$797.0K$0$0····
R&D Expense $73M$82M$72M$61M$51M$42M$30M$20M
SG&A Expense $44M$62M$36M$27M$25M$21M$18M$9M
Operating Expenses ·$39M$108M$88M$85M$63M$52M$29M
Operating Income $-87M$-36M$-108M$-88M$-85M$-60M$-52M$-29M
Interest Expense ··$6M$4M$4M$3M$2M$720.0K
Interest Income $5M$6M$5M$219.0K$10.0K$273.0K$1M$236.0K
Other Non-op $-753.0K$332.0K$554.0K$-4M$426.0K$905.0K$517.0K$0
Pretax Income $-79M$-37M$-101M$-94M$-89M$-62M$-53M$-33M
Income Tax $41.0K$310.0K$78.0K$28.0K$17.0K$148.0K$0$0
Net Income $-79M$-37M$-101M$-94M$-89M$-62M$-53M$-33M
EPS (Basic) $-1.87$-5.59$-17.07$-1.52$-3.99$-3.09··
EPS (Diluted) $-1.87$-5.59$-17.07$-1.52$-3.99$-3.09··
Shares (Basic) 42,292,8186,702,0735,927,08263,525,84525,748,79720,077,000··
Shares (Diluted) 42,292,8186,702,0735,927,08263,525,84525,748,79720,077,000··
EBITDA $-86M$-36M$-107M$-87M$-85M$-60M$-52M$-46M
Balance Sheet 26
Metric Trend 20252024202320222021202020192018
Cash & Equivalents $217M$56M$99M$122M$82M$79M$126M$8M
Receivables $573.0K$1M$0···$0·
Inventory ·$3M$0·····
Prepaid Expense $4M$6M$7M$6M$5M$4M$1M$1M
Current Assets $262M$112M$122M$129M$88M$83M$129M$9M
PP&E (Net) $182.0K$776.0K$745.0K$1M$2M$1M$403.0K$241.0K
PP&E (Gross) $1M$3M$2M$2M$2M$2M$667.0K$417.0K
Accum. Depreciation $1M$2M$2M$1M$724.0K$274.0K$264.0K$176.0K
Goodwill $17M$17M$17M$17M$17M$27M$27M$0
Intangibles $9M$10M$0·····
Other Non-current Assets $692.0K$2M$1M$1M$2M$3M$2M$364.0K
Total Assets $290M$146M$147M$156M$117M$123M$161M$10M
Accounts Payable $6M$9M$9M$8M$4M$3M$2M$3M
Accrued Liabilities $19M$23M$13M$12M$8M$8M$6M$3M
Current Liabilities $26M$33M$23M$22M$14M$12M$9M$8M
Capital Leases $0$1M$3M$4M$5M$4M$2M·
Other Non-current Liabilities $525.0K$831.0K$432.0K$173.0K$826.0K$462.0K$16.0K$205.0K
Total Liabilities $104M$124M$96M$82M$53M$50M$31M$22M
Long-term Debt $75M$75M$55M$32M$32M$32M$20M$10M
Total Debt ··$55M$34M$34M·$20M·
Common Stock $91.0K$6.0K$167.0K$122.0K$28.0K$16.0K$16.0K$0
Retained Earnings $-595M$-515M$-478M$-377M$-283M$-194M$-132M$-79M
AOCI $-109.0K$-122.0K$-119.0K$-119.0K$-119.0K$-119.0K$-119.0K$0
Stockholders' Equity $186M$22M$51M$74M$64M$73M$129M$-77M
Liabilities + Equity $290M$146M$147M$156M$117M$123M$161M$10M
Shares Outstanding 90,906,9205,698,231167,434,595121,667,25028,127,65716,305,73116,128,862351,652
Cash Flow 17
Metric Trend 20252024202320222021202020192018
D&A $1M$796.0K$419.0K$513.0K$499.0K$351.0K$103.0K$103.0K
Stock-based Comp $4M$8M$9M$5M$6M$5M$2M$759.0K
Amort. of Intangibles ·$500.0K$0$0····
Restructuring $7M$861.0K·····$2M
Other Non-cash $-12M$-102M$-4M$11M$11M$-2M$3M$-4M
Operating Cash Flow $-86M$-131M$-97M$-77M$-71M$-59M$-48M$-25M
CapEx $0$326.0K$60.0K$103.0K$615.0K$1M$174.0K$0
Investing Cash Flow $8M$67M$-15M$-103.0K$-615.0K$-1M$27M$0
Net Debt Issued $0$0$-2M$-795.0K$0$0$-9M$-5M
Stock Issued $239M$0$60M·····
Stock Repurchased ··$0$0$2M$0$0·
Net Stock Activity $239M·$0$0$-2M···
Financing Cash Flow $239M$20M$89M$117M$74M$12M$141M$7M
Net Change in Cash $161M$-44M$-23M$40M$2M$-47M$120M$-19M
Taxes Paid $338.0K·······
Free Cash Flow $-86M$-131M$-97M$-77M$-72M$-60M$-48M$-41M
Levered FCF ··$-102M$-81M$-75M$-63M··
Profitability 7
Metric Trend 20252024202320222021202020192018
Operating Margin -1336.7%-1423.6%···-1995.8%·-1311.0%
Net Margin -1218.5%-1464.6%···-2071.0%·-1229.2%
Pretax Margin -1217.8%-1452.5%···-2066.1%·-1229.2%
EBITDA Margin -1317.0%-1392.5%···-1984.1%·-1306.6%
ROA -36.2%-25.5%-66.8%-68.8%-73.9%-43.8%-61.9%-73.4%
ROE -83.2%-91.6%-170.5%-138.1%-133.3%-76.5%-50.7%193.4%
ROIC -46.7%-165.7%-101.8%-81.4%-86.6%-82.4%··
Liquidity & Solvency 5
Metric Trend 20252024202320222021202020192018
Current Ratio 10.23.45.35.86.37.013.76.5
Quick Ratio 8.41.74.35.55.86.613.45.7
Debt / Equity ··1.10.50.5·0.2·
LT Debt / Equity ··1.10.40.5·0.2·
Interest Coverage ··-18.6-21.9-23.4-22.3-24.1-44.2
Efficiency 3
Metric Trend 20252024202320222021202020192018
Asset Turnover 0.00.0·0.00.00.0·0.1
Inventory Turnover ·0.6······
Receivables Turnover 7.94.8······
Per Share 5
Metric Trend 20252024202320222021202020192018
Book Value / Share $2.05$0.13$0.31$0.61$2.29$4.46$8.01$1.48
Revenue / Share $0.15$0.01·$0.00····
Cash Flow / Share $-2.02$-0.65$-0.54$-1.21····
Cash / Share $2.39$0.33$0.59$1.00$2.91$4.83$7.82$2.11
EPS (TTM) $-1.87$-5.59$-17.07$-1.52$-3.99$-3.09··
Growth Rates 2
Metric Trend 20252024202320222021202020192018
Revenue YoY 150.0%·······
Revenue CAGR 5Y 16.7%·······
Valuation (TTM) 13
Metric Trend 20252024202320222021202020192018
Revenue TTM $6M$3M$0$0$0$3M$0$0
Net Income TTM $-79M$-37M$-101M$-94M$-89M$-62M$-53M$-33M
Market Cap $364M$3.76B$4.21B$3.62B$1.93B$3.15B$5.18B$6.09B
Enterprise Value ··$4.17B$3.54B$1.88B·$5.07B·
P/E -2.1-3.9-1.5-19.6-17.2-62.4··
P/S 55.91447.8···1048.5··
P/B 2.0170.082.548.930.043.240.1281.7
P / Tangible Book 2.3·124.963.941.168.8··
P / Cash Flow -4.2-28.8-43.7-47.0-27.3-53.5-107.7-148.8
P / FCF -4.2-28.7-43.6-46.9-27.0-52.3-107.3-148.7
EV / EBITDA ··-38.9-40.6-22.3·-98.3·
EV / FCF ··-43.2-45.8-26.3·-105.1·
Earnings Yield -46.8%-25.4%-67.8%-5.1%-5.8%-1.6%··

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $6M $3M $0 $0 $0
Operating Margin % -1336.7% -1423.6% · · ·
Net Income $-79M $-37M $-101M $-94M $-89M
Diluted EPS $-1.87 $-5.59 $-17.07 $-1.52 $-3.99

Institutional owners (13F) 93 filers · $463.3M total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 93
Value held $463.3M
New positions 36
Exited positions 26
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
36 (+18 vs prior Q) 26 (+17 vs prior Q) 23 (+1 vs prior Q) 13 (-8 vs prior Q) +8.7M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
MORGAN STANLEY $44,184,173 9,461,279 9.54% Shares
FMR LLC $38,862,138 8,321,657 8.39% Shares
Bain Capital Life Sciences Investors, LLC $37,208,011 7,967,454 8.03% Shares
PERCEPTIVE ADVISORS LLC $37,049,403 7,933,491 8.00% Shares
Saturn V Capital Management LP $32,565,512 6,973,343 7.03% Shares
Empery Asset Management, LP $32,365,860 6,930,591 6.99% Shares
Deep Track Capital, LP $27,453,795 5,878,757 5.93% Shares
BlackRock, Inc. $25,941,411 5,554,906 5.60% Shares
Kalehua Capital Management LLC $17,385,663 3,722,840 3.75% Shares
VANGUARD CAPITAL MANAGEMENT LLC $17,353,062 3,715,859 3.75% Shares
Rosalind Advisors, Inc. $15,012,957 3,214,766 3.24% Shares
VANGUARD GROUP INC $13,694,648 3,423,662 2.96% Shares
BRAIDWELL LP $13,649,261 2,922,754 2.95% Shares
Blackstone Inc. $12,524,576 2,681,922 2.70% Shares
Trails Edge Capital Partners, LP $12,008,803 2,571,478 2.59% Shares
Nantahala Capital Management, LLC $11,439,016 2,449,468 2.47% Shares
BVF INC/IL $10,431,575 2,233,742 2.25% Shares
GEODE CAPITAL MANAGEMENT, LLC $9,800,562 2,098,047 2.12% Shares
Venrock Adviser, LLC $9,032,962 1,934,253 1.95% Shares
SAMSARA BIOCAPITAL, LLC $6,517,391 1,395,587 1.41% Shares
STATE STREET CORP $6,052,399 1,296,017 1.31% Shares
Woodline Partners LP $4,675,114 1,001,095 1.01% Shares
GOLDMAN SACHS GROUP INC $4,280,223 916,536 0.92% Shares
NORTHERN TRUST CORP $3,048,805 652,849 0.66% Shares
VANGUARD FIDUCIARY TRUST CO $2,671,417 572,038 0.58% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $2,531,738 542,128 0.55% Shares
Verdad Advisers, LP $1,644,274 352,093 0.35% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $1,229,443 263,264 0.27% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $1,168,901 250,300 0.25% Call option
Caption Management, LLC $1,167,500 250,000 0.25% Call option
Stonepine Capital Management, LLC $1,050,699 224,989 0.23% Shares
Bank of New York Mellon Corp $916,908 196,340 0.20% Shares
Affinity Asset Advisors, LLC $677,150 145,000 0.15% Shares
Nuveen, LLC $501,507 107,389 0.11% Shares
Invesco Ltd. $451,926 96,772 0.10% Shares
ALPS ADVISORS INC $447,040 95,726 0.10% Shares
RHUMBLINE ADVISERS $444,022 95,081 0.10% Shares
Susquehanna Portfolio Strategies, LLC $407,607 87,282 0.09% Shares
DEUTSCHE BANK AG\ $368,393 78,885 0.08% Shares
AMERICAN CENTURY COMPANIES INC $349,293 74,795 0.08% Shares
CITIGROUP INC $327,423 70,112 0.07% Shares
WELLS FARGO & COMPANY/MN $316,215 67,712 0.07% Shares
Palumbo Wealth Management LLC $313,432 67,116 0.07% Shares
Squarepoint Ops LLC $313,254 67,078 0.07% Shares
UBS Group AG $271,060 58,043 0.06% Shares
WELLINGTON MANAGEMENT GROUP LLP $241,906 51,800 0.05% Shares
MetLife Investment Management, LLC $224,015 47,969 0.05% Shares
BANK OF AMERICA CORP /DE/ $218,841 46,861 0.05% Shares
Point72 Asset Management, L.P. $191,806 41,072 0.04% Shares
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. $173,131 37,073 0.04% Shares

Show all 93 institutional owners →

Activists & 5%+ owners 10 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Growth Equity Opportunities 18 VGE, LLC, NEA 18 Venture Growth Equity, L.P., NEA Partners 18 VGE, L.P., NEA 18 VGE GP, LLC, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Edward T. Mathers, Scott D. Sandell, Paul Walker, Rick Yang ×5 filings Oct. 29, 2025 6.20% Amendment Passive investment SEC
Coastlands Capital LP, Coastlands Capital Partners LP, Coastlands Capital GP LLC, Coastlands Capital LLC, Matthew D. Perry Aug. 18, 2025 9.99% Initial filing · SEC
Bain Capital Life Sciences Fund, L.P., Bain Capital Life Sciences Fund II, L.P., BCIP Life Sciences Associates, LP, BCLS II Investco, LP, BCLS I Investco, LP Aug. 13, 2025 9.99% Initial filing · SEC
Polaris Venture Partners V, L.P. (“PVP V”), Polaris Venture Partners Entrepreneurs’ Fund V, L.P. (“PVPE V”), Polaris Venture Partners Founders’ Fund V, L.P. (“PVPFF V”), Polaris Venture Partners Special Founders’ Fund V, L.P. (“PVPSFF V”), Polaris Venture Management Co. V, L.L.C. (“PVM V”), Jonathan A. Flint, Terrance G. McGuire ×2 filings July 17, 2019 · Initial filing · SEC
May 28, 2019 · Initial filing · SEC
Paula Ragan, Ph.D. ×2 filings April 26, 2019 · Initial filing M&A / sale SEC
OrbiMed Advisors LLC, OrbiMed Capital GP IV LLC ×3 filings March 19, 2019 · Initial filing · SEC
X4 Pharmaceuticals, Inc. Dec. 6, 2018 · Initial filing M&A / sale SEC
SVLSF V, LLC, SV Life Sciences Fund V, L.P., SV Life Sciences Fund V Strategic Partners, L.P., SV Life Sciences Fund V (GP), L.P., SVLSF VI, LLC, SV Life Sciences Fund VI, LP., SV Life Sciences Fund VI Strategic Partners, L.P., SV Life Sciences Fund VI (GP), L.P. Feb. 14, 2018 · Initial filing Passive investment SEC
New Enterprise Associates 16, L.P., NEA Partners 16, L.P., NEA 16 GP, LLC, Peter J. Barris, Forest Baskett, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Joshua Makower, David M. Mott, Chetan Puttagunta, Jon M. Sakoda, Scott D. Sandell, Peter W. Sonsini, Ravi Viswanathan Nov. 29, 2017 · Initial filing Passive investment SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 39 insiders · 17 officers · 21 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Paula Ragan President and CEO Feb. 12, 2025 A 3,337,386 0 0 $0
Michael Gray President, CEO and CFO Nov. 27, 2018 A 250,000 0 0 $0
David Kirske Chief Financial Officer June 30, 2026 S 167,750 0 2 $-109,156
Adam S. Mostafa Chief Financial Officer Feb. 12, 2025 A 850,000 0 0 $0
John Volpone President Aug. 12, 2026 S 265,305 0 1 $-109,117
Mary Dibiase Chief Operating Officer Feb. 12, 2025 A 1,140,980 0 0 $0
Adam R Craig Executive Chairman Aug. 12, 2026 S 328,651 0 1 $-210,616
Natasha Fay Thoren Chief Legal Officer May 20, 2025 A 9,462 0 0 $0
Mark Baldry Chief Commercial Officer May 16, 2025 A 25,337 0 0 $0
Christophe Arbet-Engels Chief Medical Officer Feb. 12, 2025 A 864,207 0 0 $0
Arthur Taveras Chief Scientific Officer Oct. 7, 2024 S 388,026 0 0 $0
Derek M Meisner Chief Legal Officer Aug. 17, 2022 S 145,155 0 0 $0
Diego Cadavid Chief Medical Officer March 1, 2022 A 104,107 0 0 $0
Renato Skerlj Chief Scientific Officer Sept. 9, 2020 S 42,076 0 0 $0
Lynne E Kelley Chief Medical Officer April 24, 2019 A · 0 0 $0
Eszter Nagy Chief Scientific Officer March 7, 2018 A · 0 0 $0
David Mantus Chief Development Officer March 7, 2018 A · 0 0 $0
Kelly Gold Director July 1, 2026 A · 0 0 $0
Francoise De Craecker Director Jan. 1, 2026 A 4,722 0 0 $0
Murray Stewart Director Jan. 1, 2026 A 7,883 0 0 $0
Gary Bridger Director Jan. 1, 2026 A 4,722 0 0 $0
Michael S Wyzga Director Jan. 1, 2026 A 5,555 0 0 $0
Keith Woods Director June 9, 2025 A 6,000 0 0 $0
William Aliski Director June 10, 2024 A 96,667 0 0 $0
Alison Frances Lawton Director June 10, 2024 A 96,667 0 0 $0
David W J Mcgirr Director June 10, 2024 A 96,667 0 0 $0
Rene Russo Director June 2, 2021 A · 0 0 $0
Isaac Blech Director March 13, 2019 A · 0 0 $0
Tillman U. Gerngross Director June 5, 2018 A 392,821 0 0 $0
Claudio Nessi Director June 5, 2018 A 867,639 0 0 $0
Amy Schulman Director June 5, 2018 A · 0 0 $0
William D Clark Director June 5, 2018 A · 0 0 $0
GORDON CARL L Director June 5, 2018 A 1,868,966 0 0 $0
Terrance McGuire Director June 5, 2018 A 18,031 0 0 $0
Michael Jay Ross Director Nov. 15, 2017 A 1,868,961 0 0 $0
Anna-Maria & Stephen Kellen Foundation, Inc. 10% owner Nov. 20, 2017 C 124,381 0 0 $0
Bill & Melinda Gates Foundation 10% owner Nov. 20, 2017 C 722,179 0 0 $0
Alexandria Venture Investments, LLC 10% owner Nov. 15, 2017 C 225,680 0 0 $0
Anthony Chris Stevens · March 7, 2018 A · 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 11 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
QQQS · Invesco Exchange-Traded Fund Trust … 0.37% 29,512 SH Oct. 1, 2026 Daily
IWC · iShares Trust 0.06% 273,306 SH Sept. 11, 2026 Daily
VTWV · VANGUARD SCOTTSDALE FUNDS 0.02% 70,293 SH Aug. 19, 2026 Daily
RSSL · Global X Funds 0.01% 38,483 NS July 31, 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0.01% 464,950 SH Aug. 19, 2026 Daily
IWM · iShares Trust 0.01% 2,014,836 SH Sept. 11, 2026 Daily
PRFZ · Invesco Exchange-Traded Fund Trust 0.01% 49,598 SH Sept. 30, 2026 Daily
VXF · VANGUARD INDEX FUNDS 0.00% 1,031,672 SH Aug. 19, 2026 Daily
VTI · VANGUARD INDEX FUNDS 0.00% 2,599,387 SH Aug. 19, 2026 Daily
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 6,885 SH Aug. 19, 2026 Daily
IWN · iShares Trust · 753,604 SH Sept. 11, 2026 Daily

XFOR Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 11 analysts BUY
Median target $12.00 +324.0%
5 45.5% Strong Buy
5 45.5% Buy
1 9.1% Hold
0 0.0% Sell
0 0.0% Strong Sell

12-Month Price Target

5 analysts · 2026-09-29

Mean target $11.60 +309.9%

← Below all targets Current price $2.83
Low$10.00 Mean$11.60 High$13.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
XFOR $364M -2.1 150.0% -1218.5% -83.2% ·
RZLT $501M -6.9 · · -67.8% ·
KYTX $568M -2.6 · · -77.4% ·
IRD $140M -2.5 29.1% -349.3% -302.2% ·
AGEN $111M · 10.4% -2.7% 1.0% ·
ENTA $256M -3.1 -3.4% -125.4% -103.5% ·
ARCT $174M -2.6 -46.1% -80.2% -29.6% ·
INDP $6M -0.1 · · -2820.8% ·
CCCC $185M -1.5 1.0% -292.1% -48.8% ·

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed Aug 6, 2026